Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

B7 Coreceptor Molecules as Clinically-Relevant Surrogate Biomarkers in the Hyper IgD Syndrome (HIDS) Form of Mevalonate Kinase Deficiency (MKD)

NCT01568736 is registered in ClinicalTrials.gov with Michigan Technological University as lead sponsor.

NCT NCT01568736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01568736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
B7 Coreceptor Molecules as Clinically-Relevant Surrogate Biomarkers in the Hyper IgD Syndrome (HIDS) Form of Mevalonate Kinase Deficiency (MKD)
Lead sponsor
Michigan Technological University
Phase
Observational
Overall status
Withdrawn
Start date
March 31, 2012
Completion date
March 31, 2016
Enrollment
0 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hyper igd syndrome, mevalonate kinase deficiency